
28 & 29 September 2023
ANF – Associação Nacional das Farmácias | Lisbon, Portugal
We are counting down! There are only:
Day(s)
:
Hour(s)
:
Minute(s)
:
Second(s)
OPEN FOR REGISTRATIONS
Framework
In the past few years, the medical cannabis industry has experienced exponential growth with the legalization to sell and consume medicinal cannabis products, in several countries in Europe. The increasing demand for these products and the profit margins associated, led several investors to invest in the medicinal cannabis market. According to several analysts, this market size has the potential to reach 3.2 billion euros by the end of 2025.
In this context, the medical cannabis industry, as well as all involved stakeholders are facing the main challenge of interpretation and be compliance with EU-GACP and EU-GMP regulations to be able to place cannabis-based products for medicinal purposes on the market demonstrating consistency, quality, efficacy and patient safety.
These are the mandatory assumptions for health authorities and patients’ confidence in the medical cannabis industry, which will lead to the development of this market in Portugal.

Purpose
The Medical Cannabis Europe Conference was specially developed to debate and clarify doubts regarding the applicable regulations to the cultivation, manufacture and distribution of cannabis-based products for medicinal purposes in Portugal and Europe. This conference will feature international and local experts on medical cannabis that will provide insights into the European market and address aspects such as applicable regulations and expectations of the authority in licensing inspections.
Program
Dia 28
Program
09h00 | 9h30
Opening Session
Miguel Samora, ANF
Fátima Carvalho, LEF
Carla Dias, OPCM
Félix Carvalho, Ordem dos Farmacêuticos
09h30 | 10h15
What’s New: Cannabis market in Europe and Portugal – past, present and future
Hermano Rodrigues, EY-Parthenon
10h15 | 11h15
Cannabis cultivation – current trends
Xavier G., Klonetics
David Martín, Head of Scientific Expansion at MyFloraDNA
José Manuel Guerrero, Novagric
11h15 | 11h45
Coffee Break
11h45 | 12h15
Major milestones in the history of Cannabis
João Neto, Museu da Farmácia
12h15 | 13h15
From product development to market
Rui Soares, Paralab
Ana Francisca Bettencourt, iMed
13h15 | 14h30
Lunch Break
14h30 | 15h15
Market trends on cannabis products
Heitor Costa, Apifarma
Giadha A. DeCarcer, Ctrust
15h15 | 16h00
Demonstration of Clinical evidence
Mariana Romão, CEFAR
Ricardo Cuha, Blueclinical
16h00 | 16h30
Coffee Break
16h30 | 18h00
The Q Roles in Cannabis Industry | Round table
Robert Smallman, Cureleaf
Inês Vieira, Keyleaves
José Veracruz, Canna.biz
José Meneses, Presidente da Associação Portuguesa de Diretores de Segurança
Farida Hussain, Dovetail Consulting (moderador)
18h00 | 18h15
Closing session 1st day
Aldo Vidinha, Stepsciense Pharma & Engineering
18h15 | 19h30
Wine & Cheese moment with the announceument of the Best Scientific Poster
day 29
Program
08h55 | 9h00
Opening Session
Fátima Carvalho, LEF
09h00 | 10h45
Inspection & Product Registration trends
Helena Correia, Consultant
Sérgio Neto, Cannacare
Luís Meitinhos Soares, Cannavigia
10h45 | 11h15
Coffee Break
11h15 | 12h00
Qualification & Validation – current expectations
Miguel Abelho, Stepscience Pharma Engineering
Andreia Monteiro & Sara Figueiredo, LEF
12h00 | 13h15
Transport and Import/Export requirements
Joel Caria, Alloga Logifarma
Joana Silveira Botelho, Cuatrecasas
Gonçalo Pereira, Polícia Segurança Pública (PSP)
13h15 | 14h00
Lunch Break
14h00 | 15h15
Business sustainability
Margarida Mesquita Carvalho, Bluepharma
Bernardo Augusto & Inez Agoas, Capgemini Portugal
Viviane Sedola, Entrepreneur
15h15 | 16h00
Compliance challenges in software systems
Luís Meirinhos Soares, Cannavigia
16h00 | 16h15
Closing session
Aldo Vidinha, Stepscience Pharma & Engineering
Live Event
Preços
Bilhete Standard:
730€ + IVA (2 dias)
Daily Ticket
490€ + IVA (1dia)
Inclui:
Lunch, Coffee Breaks, Wine & Cheese Moment and a visit to the Pharmacy Museum.
Attendees
The conference is orientated to all entities involved in the medical cannabis industry, from:
Investors, growers, holders of pharmaceutical manufacture licenses, manufacturers, suppliers, importers / exporters, technical directors and quality technicians and ever health authority inspectors.
Speakers
Mariana
Romão
RWE and Outcomes Research Manager at CEFAR – Center for Health Evaluation and Research